<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Xiao Y</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>The optimal imaging modality and diagnostic criteria for accurately detecting and characterizing subcentimeter hepatocellular carcinoma (HCC) remain uncertain, and this study aims to compare performance of gadoxetic acid-enhanced MRI (EOB-MRI) and extracellular contrast agent-enhanced MRI (ECA-MRI) in detecting and characterizing subcentimeter HCC.&lt;h4>Methods&lt;/h4>A total of 1,022 patients at risk of HCC (mean age, 53.80 ± 11.24, 732 men) with 1,210 subcentimeter hepatic lesions were retrospectively included. Lesion detection rate and HCC characterization performance were calculated and compared between EOB-MRI and ECA-MRI sets using generalized estimating equation method.&lt;h4>Results&lt;/h4>Consensually, EOB-MRI demonstrated significantly higher sensitivity for detecting subcentimeter hepatic lesions compared to ECA-MRI (0.995 vs. 0.953, &lt;i>p&lt;/i> &lt; 0.001). EOB-MRI and ECA-MRI showed comparable performance in characterizing subcentimeter HCC based on typical vascular pattern (sensitivity, 0.382 vs. 0.457, &lt;i>p&lt;/i> = 0.064; specificity 0.941 vs. 0.933, &lt;i>p&lt;/i> = 0.462). After applying modified criteria, the sensitivities (EOB-MRI: 0.382 vs. 0.812, &lt;i>p&lt;/i> &lt; 0.001; ECA-MRI: 0.457 vs. 0.574, &lt;i>p&lt;/i> &lt; 0.001) were significantly increased on both MRIs by consensus reading, while specificities did not differ a lot (EOB-MRI: 0.859 vs. 0.941, &lt;i>p&lt;/i> = 0.012; ECA-MRI: 0.894 vs. 0.933, &lt;i>p&lt;/i> = 0.084). And compared with ECA-MRI, EOB-MRI exhibited significantly higher sensitivity (0.812 vs. 0.574, &lt;i>p&lt;/i> &lt; 0.001) based on modified criteria, without a substantial loss of specificity (0.859 vs. 0.894, &lt;i>p&lt;/i> = 0.162).&lt;h4>Conclusion&lt;/h4>EOB-MRI with modified criteria exhibited superior detection and characterization performance of subcentimeter HCC when compared with ECA-MRI in patients at risk of HCC, thus offering clinicians more opportunities to accurately identify high-risk subcentimeter lesions.</pubmed_abstract><journal>Liver cancer</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12503752</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Detection and Characterization of Subcentimeter Hepatocellular Carcinoma: A Comparison of Gadoxetic Acid-Enhanced and Extracellular Contrast Agent-Enhanced MRI.</pubmed_title><pmcid>PMC12503752</pmcid><pubmed_authors>Liang X</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Zhou C</pubmed_authors><pubmed_authors>Xiao Y</pubmed_authors><pubmed_authors>Zeng M</pubmed_authors><pubmed_authors>Jia X</pubmed_authors><pubmed_authors>Wu F</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Yang C</pubmed_authors><pubmed_authors>Huang P</pubmed_authors><pubmed_authors>Dai H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Detection and Characterization of Subcentimeter Hepatocellular Carcinoma: A Comparison of Gadoxetic Acid-Enhanced and Extracellular Contrast Agent-Enhanced MRI.</name><description>&lt;h4>Introduction&lt;/h4>The optimal imaging modality and diagnostic criteria for accurately detecting and characterizing subcentimeter hepatocellular carcinoma (HCC) remain uncertain, and this study aims to compare performance of gadoxetic acid-enhanced MRI (EOB-MRI) and extracellular contrast agent-enhanced MRI (ECA-MRI) in detecting and characterizing subcentimeter HCC.&lt;h4>Methods&lt;/h4>A total of 1,022 patients at risk of HCC (mean age, 53.80 ± 11.24, 732 men) with 1,210 subcentimeter hepatic lesions were retrospectively included. Lesion detection rate and HCC characterization performance were calculated and compared between EOB-MRI and ECA-MRI sets using generalized estimating equation method.&lt;h4>Results&lt;/h4>Consensually, EOB-MRI demonstrated significantly higher sensitivity for detecting subcentimeter hepatic lesions compared to ECA-MRI (0.995 vs. 0.953, &lt;i>p&lt;/i> &lt; 0.001). EOB-MRI and ECA-MRI showed comparable performance in characterizing subcentimeter HCC based on typical vascular pattern (sensitivity, 0.382 vs. 0.457, &lt;i>p&lt;/i> = 0.064; specificity 0.941 vs. 0.933, &lt;i>p&lt;/i> = 0.462). After applying modified criteria, the sensitivities (EOB-MRI: 0.382 vs. 0.812, &lt;i>p&lt;/i> &lt; 0.001; ECA-MRI: 0.457 vs. 0.574, &lt;i>p&lt;/i> &lt; 0.001) were significantly increased on both MRIs by consensus reading, while specificities did not differ a lot (EOB-MRI: 0.859 vs. 0.941, &lt;i>p&lt;/i> = 0.012; ECA-MRI: 0.894 vs. 0.933, &lt;i>p&lt;/i> = 0.084). And compared with ECA-MRI, EOB-MRI exhibited significantly higher sensitivity (0.812 vs. 0.574, &lt;i>p&lt;/i> &lt; 0.001) based on modified criteria, without a substantial loss of specificity (0.859 vs. 0.894, &lt;i>p&lt;/i> = 0.162).&lt;h4>Conclusion&lt;/h4>EOB-MRI with modified criteria exhibited superior detection and characterization performance of subcentimeter HCC when compared with ECA-MRI in patients at risk of HCC, thus offering clinicians more opportunities to accurately identify high-risk subcentimeter lesions.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-04T09:03:18.508Z</modification><creation>2026-05-07T03:12:13.008Z</creation></dates><accession>S-EPMC12503752</accession><cross_references><pubmed>41063743</pubmed><doi>10.1159/000547751</doi></cross_references></HashMap>